Trexquant Investment’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Trexquant Investment’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,610	Closed	-$2.14M	–	1916
2023 Q1	$2.14M	Buy	+19,610	New	+$2.17M	0.06%	436
2022 Q4	–	Sell	-26,079	Closed	-$1.61M	–	1859
2022 Q3	$1.61M	Sell	26,079 -25,369	-49%	-$1.77M	0.06%	396
2022 Q2	$4.1M	Sell	51,448 -12,736	-20%	-$1.21M	0.18%	128
2022 Q1	$6.75M	Buy	64,184 +43,688	+213%	+$4.26M	0.32%	67
2021 Q4	$2.21M	Buy	+20,496	New	+$2.24M	0.14%	186
2021 Q2	–	Sell	-21,973	Closed	-$2.02M	–	1666
2021 Q1	$2.02M	Buy	+21,973	New	+$1.85M	0.19%	142
2020 Q1	–	Sell	-10,079	Closed	-$365K	–	1581
2019 Q4	$365K	Buy	+10,079	New	+$309K	0.02%	671
2019 Q1	–	Sell	-42,525	Closed	-$831K	–	1474
2018 Q4	$831K	Buy	+42,525	New	+$834K	0.05%	473
2018 Q2	–	Sell	-141,421	Closed	-$2.01M	–	1399
2018 Q1	$2.01M	Buy	+141,421	New	+$2.09M	0.14%	245
2017 Q4	–	Sell	-16,453	Closed	-$209K	–	1353
2017 Q3	$209K	Sell	16,453 -6,347	-28%	-$80.7K	0.05%	620
2017 Q2	$271K	Sell	22,800 -24,600	-52%	-$306K	0.07%	515
2017 Q1	$701K	Buy	+47,400	New	+$768K	0.09%	398
2016 Q4	–	Sell	-77,100	Closed	-$1.4M	–	1227
2016 Q3	$1.4M	Buy	77,100 +15,733	+26%	+$307K	0.31%	69
2016 Q2	$1.01M	Buy	61,367 +43,206	+238%	+$699K	0.13%	233
2016 Q1	$301K	Sell	18,161 -22,560	-55%	-$395K	0.04%	733
2015 Q4	$882K	Buy	40,721 +17,521	+76%	+$341K	0.08%	437
2015 Q3	$459K	Sell	23,200 -7,600	-25%	-$240K	0.04%	755
2015 Q2	$1.07M	Buy	+30,800	New	+$940K	0.12%	298
2015 Q1	–	Sell	-30,858	Closed	-$397K	–	1293
2014 Q4	$397K	Buy	+30,858	New	+$386K	0.07%	564

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Trexquant Investment's HZNP Position: Q2 2023 in Review

Trexquant Investment sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 19,610 shares — an estimated $2.14M sold.

Trexquant Investment first reported a position in HZNP in Q4 2014 and held it in 19 quarters. The position peaked at $6.75M in Q1 2022. 517 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Trexquant Investment reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Trexquant Investment sold 19,610 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $2.14M.
Trexquant Investment first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and held it in 19 quarters.
Trexquant Investment's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.75M in Q1 2022.
517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Trexquant Investment's 13F filing for Q2 2023, filed 11 Aug 2023.